PBT
BIIB icon

Pictet Bank & Trust’s Biogen BIIB Stock Holding History

Pictet Bank & Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-860
Closed -$251K – 88
2015
Q3 		$251K Buy
+860
New +$284K 0.09% 98
2015
Q1 		– Sell
-660
Closed -$224K – 83
2014
Q4 		$224K Hold
660
– – 0.09% 88
2014
Q3 		$218K Hold
660
– – 0.09% 93
2014
Q2 		$208K Hold
660
– – 0.08% 94
2014
Q1 		$202K Buy
+660
New +$210K 0.08% 88

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pictet Bank & Trust's BIIB Position: Q4 2015 in Review

Pictet Bank & Trust sold out of Biogen (BIIB) in Q4 2015, closing a stake of 860 shares — an estimated $251K sold.

Pictet Bank & Trust first reported a position in BIIB in Q1 2014 and held it in 5 quarters. The position peaked at $251K in Q3 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Pictet Bank & Trust reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • Pictet Bank & Trust sold 860 Biogen shares in Q4 2015, an estimated $251K.
  • Pictet Bank & Trust first reported a position in Biogen in Q1 2014 and held it in 5 quarters.
  • Pictet Bank & Trust's Biogen position peaked at $251K in Q3 2015.
  • 970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Pictet Bank & Trust's 13F filing for Q4 2015, filed 3 Feb 2016.